La Administracin de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en ingls) aprob este mircoles la segunda pldora GLP-1 para la prdida de peso, lo que aade otra opcin a un arsenal de tratamientos contra la obesidad en rpido crecimiento

Wegovy highlights of prescribing information, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Alcohol and diabetes, American Diabetes Association (2024) Rybelsus highlights of prescribing information, Food and Drug Administration (2024) Food sources of dietary fiber, Dietary Guidelines for Americans (2024) Semaglutide injection, MedlinePlus (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

LifeRx sends an email stating please do not do anything with the medication until you have spoken with a patient care specialist, even though written instructions are included in that same email as well as via a QR code in the box
Once-Weekly Injection: The convenience of a once-weekly injection makes Semaglutide an attractive option for patients